Wragge advises biopharmaceutical company arGEN-X on collaboration and alliance
Wragge Lawrence Graham & Co’s life sciences team has advised Netherlands- and Belgium-based biopharmaceutical company arGEN-X on its first collaboration with Bayer to discover and develop therapeutic antibody candidates and on a strategic alliance with Shire. Both deals were completed in the same week. arGEN-X is a clinical-stage biopharmaceutical company focused on creating and developing […]